Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.1M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
4.41M
-
Shares change
-
-440K
-
Total reported value, excl. options
-
$4.76M
-
Value change
-
-$982K
-
Put/Call ratio
-
0.57
-
Number of buys
-
13
-
Number of sells
-
-14
-
Price
-
$1.08
Significant Holders of HOOKIPA Pharma Inc. - Common Stock, par value $0.0001 per share (HOOK) as of Q1 2025
41 filings reported holding HOOK - HOOKIPA Pharma Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
HOOKIPA Pharma Inc. - Common Stock, par value $0.0001 per share (HOOK) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.41M shares
of 12.1M outstanding shares and own 36.47% of the company stock.
Largest 10 shareholders include GILEAD SCIENCES, INC. (1.88M shares), BAKER BROS. ADVISORS LP (813K shares), Siren, L.L.C. (567K shares), FMR LLC (350K shares), VANGUARD GROUP INC (301K shares), GEODE CAPITAL MANAGEMENT, LLC (73.4K shares), ACADIAN ASSET MANAGEMENT LLC (55.7K shares), Ikarian Capital, LLC (53K shares), RENAISSANCE TECHNOLOGIES LLC (41K shares), and Squarepoint Ops LLC (40.8K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.